The aim of this cohort, prospective study was to compare the diagnostic value of intrapartum fetal pulse oximetry (FPO) with that of fetal scalp blood gas (FSBG) for an abnormal neonatal outcome in cases with abnormal fetal heart rate (FHR) tracings.
INTRODUCTION
Fetal surveillance during labor is currently based primarily on Fetal Heart Rate (FHR) monitoring. However, this technique has poor specificity in that abnormal FHR is not often associated with actual fetal distress. 1, 2 Therefore the diagnosis of fetal distress may be corroborated by complementary methods such as continuous recording of the fetal electrocardiogram, fetal pulse oximetry or fetal scalp blood sampling with determination of blood gases or lactate. 3 Fetal scalp blood analysis has been used reduce the ''falsepositive'' interpetations of FHR. [4] [5] [6] However, it is an invasive technique.
Since the purpose of direct fetal monitoring is to distinguish fetuses who are at particular risk for adverse outcome from those who will remain uninjured, then reliable tests should hold a high negative predictive value (NPV). As abnormal neonatal outcomes are rare events, even a poorly efficient diagnostic test may have a relatively high NPV. To avoid this, enrolling into a study many patients including enough with suboptimal outcomes leads to assuring high sensitivity. 7 Pulse oximetry, while widely used in the intensive care units and in the routine care of patients, has been only recently used to monitor human fetuses in clinical practice. 8, 9 Most prior studies focused on evaluating the feasibility and validity as well as correlating the fetal pulse oximetry values with fetal acid-base balance. [10] [11] [12] Only a few, small prior studies have evaluated the predictive value of fetal pulse oximetry for patients with abnormal FHR. [13] [14] [15] Further, the fetal pulse oximetry sensors have evolved with newer models seemingly providing reliable real-time measurements of fetal arterial oxygen oxygen saturation levels during active labor. 16 This study was planned to evaluate fetal pulse oximetry by comparing the information provided by it with that obtained by fetal scalp blood analysis, with particular emphasis on adverse neonatal outcome.
MATERIAL AND METHODS
The study was conducted in the departments of Obstetrics and Neonatology in Alexandria University Maternity Hospital that has approximately 10,000 deliveries per year. Nearly 12% of delivered infants are admitted to the newborn unit. The study protocol was approved by the University Board. Informed consent was obtained from patients before enrollment. Only cases with abnormal FHR tracings during 1-year-period (June 2001 to May 2002) were included in the study.
Routine care was conducted for all the patients. Nellcor N-400 fetal oxygen saturation monitor and fetal sensors were applied to the fetal temples to monitor the hemoglobin oxygen saturation. An average value of 30 minutes reading was calculated. A fetal scalp blood gas sample was then taken. An umbilical cord arterial blood gas sample was obtained shortly after birth before shifting the baby from the delivery area.
Variables reflecting the neonatal outcome were collected. Abnormal neonatal outcome was defined as having any of the following: 5 minute Apgar score r7, secondary respiratory distress, transfer to a neonatal intensive care unit, neonatal arterial blood pHr7.15, or neonatal death.
The diagnostic value of both pulse oximetry and fetal blood gas analysis were analyzed as to the ability to correctly predict the two following outcomes: umbilical cord arterial pH of r7.15 or an abnormal neonatal outcome. The diagnostic value of fetal pulse oximetry was compared with that of fetal blood gas analysis at the most critical cutoff values. Following the study of Carbonne et al., 17 abnormal values were assumed at the following levels: r7.15 for fetal scalp blood gas pH (FSBG) and r30 and r40% hemoglobin saturation for fetal pulse oximetry (FPO30 and FPO40, respectively).
The statistical methods used included calculating the predictive values (positive and negative), sensitivity and specificity of different methods from the contingency tables. 95% confidence interval (CI) was used.
RESULTS
The study lasted for one year. During that period, there were 9825 deliveries. During that period, 415 fetuses were documented to have FHR tracing abnormalities. Only 150 cases fulfilled the whole screening panel (fetal pulse oximetry, fetal scalp blood gas and umbilical cord blood gas) and were included in the study. An ''abnormal neonatal outcome'', as previously defined, was observed in 38 cases (25%). An umbilical cord blood pH (r7.15) was detected in 60 cases (40%). The mean time lag between the fetal blood gas analysis and birth was 36.7±15.3 minutes. Table 1 shows the number of cases of abnormal neonatal outcome and umbilical cord blood pHr7.15 detected by FSBG, FPO30 and FPO40. When the outcome variable was the umbilical arterial pH, the positive predictive values (PPV) was highest (65, 95% CI 57 to 73) and the NPVs was lowest (35, 95% CI 27 to 43) with FPO40. The sensitivity of FPO30 was highest (75 vs 72% for FSBG and 60% for FPO40). The specificity was highest (53, 95% CI 42 to 63) for FSBG. Considering the abnormal neonatal outcome, again the sensitivity was highest for FPO30 (89, 95% CI 65 to 91) and lowest for FPO40 (76, 95% CI 59 to 88). The sensitivity of FSBG was 82%. The specificity of the three methods was 53, 49 and 38% for FSBG, FPO30 and FPO40 respectively. (Table 2) DISCUSSION Obstetric decision regarding non-reassuring FHR tracings is always a dilemma. In busy obstetric and neonatal services, the issue is even more critical. Moreover, in a developing country, where the resources are limited, the need for an accurate diagnostic technique that would ensure a good neonatal outcome without increasing unnecessary interventions is more needed. In a large multicenter randomized controlled trial, Garite et al. 18 reported that the addition of fetal pulse oximetry led to a reduction in cesarean deliveries performed because of nonreassuring fetal status. Our study explored the possibility of using FPO as such a screening tool in a developing country environment. In their study on fetuses with normal FHR tracings, Luttkus et al. 19 found the 10th percentile of FPO to be around 35%. This justified our testing of FPO cutoffs of 30 and 40%.
In the study of Carbonne et al., 17 abnormal neonatal outcome was observed in 20% of the cases, while a low umbilical cord blood pH was observed in 16% of the cases. This emphasized the importance of having a high NPV for a good screening method. However, in our population, abnormal neonatal outcome was observed in 25% of the cases vs a low umbilical cord blood pH in 40% of the cases. This stresses the value of having a high PPV. This was best observed with FPO30 for low umbilical cord blood pH and abnormal neonatal outcome. The relatively poor antenatal care in developing countries and the higher gravidity of the mothers could explain having more fetuses at risk in our study.
The NPV of FSBG, FPO30 and FPO40 were all relatively low (43, 39 and 35%, respectively). In the study of Carbonne et al., 17 these values were relatively high (88 to 89%), for the prediction of a low umbilical arterial pH and the PPV were rather low. However, as described before it seems that the type of population in our study is different from that of Carbonne et al., 17 which seemed to have more neonates at risk. This study and that of Skoczylas et al. 15 reported PPV comparable to those of our study.
In our study, the sensitivity of the screening methods were relatively high and that of FPO30 was higher than that of FSBG and FPO40 when considering both low umbilical cord blood pH and abnormal neonatal outcome. In spite of having a lower sensitivity in the study of Carbonne et al., 17 this significantly increased from 29 to 76% when the cutoff level of FPO was decreased from 40 to 30% in the prediction of an abnormal neonatal outcome. This confirms the deduction of our study that the diagnostic value of FPO during labor can be favorably compared with that of FSBG. In a German study, to evaluate the clinical usefulness of fetal pulse oximetry in evaluating nonreassuring fetal heart rate patterns, the sensitivity was low (11%). The authors concluded that fetal distress and impaired condition of the newborn are not identified or predicted during routine FPO monitoring in the fetus during labor with adequate safety. 20 However, they used a higher pH (7.25) than we (7.15) as the threshold level for determination of sensitivity.
As seen from our results, increasing the FPO threshold value from 30 to 40% has a definite drawback. At the higher level, the specificity and PPV were decreased as more otherwise normal infants would be falsely identified as at risk. Unnecessary interventions would be unduly increased. Our results show that 90% of the abnormal outcomes are identified using the FPO30 cutoff, which is not improved by using the FPO40 cutoff.
One of the limitations of our study was that the investigators were not blinded to the readings of FPO. However, it is very unlikely that this affected the management and the clinical decisions. The clinicians were instructed to ignore all FPO values and these values were then analyzed retrospectively. Another limitation was that obtaining exact simultaneous FPO and FSBG readings are practically not possible. As described before, an average value of 30 minutes reading was calculated by the machine software to give the FPO reading. Transient variations of fetal oxygen saturation, frequently observed, are probably less meaningful than long-lasting changes. Seelbach-Gobel et al. 21 reported a negative correlation between the duration of fetal oxygen saturation below 30% and umbilical cord blood pH. Waiting for a 30 minute recording time could be a limitation to the clinical application of pulse oximetry. A fourth limitation was that the umbilical arterial sampling was considered arterial as judged by the skilled sampling clinician. No validation using paired samples was done. Westgate et al. have shown a pH mean difference of about 0.02 between venous and arterial umbilical blood samples, a value that is clinically insignificant. 22 In our study, the predictive value of fetal scalp blood analysis was not as expected particularly with regard to the NPV and sensitivity. The timing interval between testing and delivery was the same as for FPO and FSBG. There was also no significant difference 23 reported that nearly 50% of cases of neonatal acidosis were not prevented by intensive fetal surveillance with FHR monitoring and fetal blood analysis. Although scalp blood analysis is still considered the gold standard of monitoring techniques, other than FHR monitoring, our results showed that FPO30 cutoff diagnostic value was very similar to that of scalp blood analysis. Similar results were reported by Kuhnert et al. 24 
CONCLUSION
We have confirmed that the FPO level of 30% oxygenated fetal blood appears as a clinically valuable threshold to separate infants with abnormal FHR that will have abnormalities in the immediate postpartum period from those that will appear normal.
